These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10322421)

  • 1. HLA-DM - an endosomal and lysosomal chaperone for the immune system.
    Vogt AB; Kropshofer H
    Trends Biochem Sci; 1999 Apr; 24(4):150-4. PubMed ID: 10322421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.
    Kropshofer H; Arndt SO; Moldenhauer G; Hämmerling GJ; Vogt AB
    Immunity; 1997 Mar; 6(3):293-302. PubMed ID: 9075930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.
    vogt AB; Moldenhauer G; Hämmerling GJ; Kropshofer H
    Immunol Lett; 1997 Jun; 57(1-3):209-11. PubMed ID: 9232453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments.
    Pierre P; Denzin LK; Hammond C; Drake JR; Amigorena S; Cresswell P; Mellman I
    Immunity; 1996 Mar; 4(3):229-39. PubMed ID: 8624813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.
    Marks MS; Roche PA; van Donselaar E; Woodruff L; Peters PJ; Bonifacino JS
    J Cell Biol; 1995 Oct; 131(2):351-69. PubMed ID: 7593164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DM and MHC class II molecules co-distribute with peptidase-containing lysosomal subcompartments.
    Fernandez-Borja M; Verwoerd D; Sanderson F; Aerts H; Trowsdale J; Tulp A; Neefjes J
    Int Immunol; 1996 May; 8(5):625-40. PubMed ID: 8671650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessory proteins that control the assembly of MHC molecules with peptides.
    Van Kaer L
    Immunol Res; 2001; 23(2-3):205-14. PubMed ID: 11444385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
    Vogt AB; Kropshofer H; Hämmerling GJ
    Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.
    Ferrari G; Knight AM; Watts C; Pieters J
    J Cell Biol; 1997 Dec; 139(6):1433-46. PubMed ID: 9396749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM.
    Pathak SS; Lich JD; Blum JS
    J Immunol; 2001 Jul; 167(2):632-5. PubMed ID: 11441064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma.
    Siegrist CA; Martinez-Soria E; Kern I; Mach B
    J Exp Med; 1995 Dec; 182(6):1793-9. PubMed ID: 7500024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional HLA-DM on the surface of B cells and immature dendritic cells.
    Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
    EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
    Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
    Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest?
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Today; 1997 Feb; 18(2):77-82. PubMed ID: 9057358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What to do with HLA-DO?
    van Ham M; van Lith M; Griekspoor A; Neefjes J
    Immunogenetics; 2000 Aug; 51(10):765-70. PubMed ID: 10970090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
    Romagnoli P; Layet C; Yewdell J; Bakke O; Germain RN
    J Exp Med; 1993 Mar; 177(3):583-96. PubMed ID: 8436902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.